MDCB Credits: 2.50
ARRT Credits: 0.75
Available Until: 10/31/2026
Non-Member Price: $87.50
Member Price: $50.00
Member PLUS Price: $50.00
Once you have exceeded your annual free credit allowance you will be prompted to pay a per-credit fee.
Courses purchased using your credit allowance are non-refundable and need to be completed before their expiration date
View your annual credit allowance here.
Authors: Jonathan Cabrera, MS ∗; Kevin Erhart, PhD†; Patrick Kelly, MD ∗; Omar A. Zeidan, PhD ∗; Cameron Swanick, MD ∗; Justin Rineer, MD ∗; Amish P. Shah, PhD ∗
∗ Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL 32806, USA
† .decimal LLC, Sanford, FL 32771, USA
Bolus electron conformal therapy (BECT) in the treatment of cancers of the head and neck is often limited by an inability to reduce dosimetric hot spots resulting from surface irregularity or tissue heterogeneity. We examined the potential bene?ts of using intensity modulation for electron therapy (IM-BECT) to reduce hotspots in patients undergoing electron beam therapy for super?cial cancers of the head and neck (HN). Twenty patients with HN cancer previously treated with BECT were identi?ed. Each case included the treatment targets and a primary organ at risk (OAR) that were de?ned by the radiation oncologist. A target +2 cm rind structure was created for analysis of the dose deposition in areas surrounding the target volume as a measure of conformality. Each patient plan was transferred into the novel IM-BECT planning software and each case was recomputed as per the original parameters. Next, each case was replanned with the inclusion of intensity modulation, as well as a new custom conformal bolus that was redesigned for optimized range compensation when paired with an intensity modulator. The plans were then normalized to prescription dose and compared for target coverage/dose and OAR dose. For patients who had a hotspot of 125% or greater, the hotspot was on average reduced by 13.1% with IM-BECT. For IM-BECT, the average primary OAR means dose and target+2cm rind mean dose increased slightly by 10.6% and 6.4%, respectively (primary OAR mean [p = 0.0001], and Target+2cm rind mean [p = 0.0001], paired t-test). IM-BECT is an effective method of reducing hotspots in patients with super?cial HN cancer. Improvements came at the expense of slight increases in dose to the underlying tissues. This retrospective planning study represents the ?rst example of IM-BECT to actual HN patient cases. Expanding the role of IM-BECT in other disease sites could potentially compared to conventional BECT.
As of January 1, 2022, ARRT requires CE Credits for Directed Journal Readings to be based on the word count for each article. So, the number of CE Credits for each DJR article will vary for ARRT. For this article, the ARRT CE Credit will be 0.75 Credit. The MDCB CE Credits will remain at 2.5 Credits.
ARRT CQR Credit Distribution
Radiation Therapy 2017:
Procedures
Treatments = 0.75
Radiation Therapy 2022
Procedures
Treatments = 0.75